phenylalanine and Cancer of the Urinary Tract

phenylalanine has been researched along with Cancer of the Urinary Tract in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hååg, P; Holmsten, K; Juntti, T; Kanter, L; Lewensohn, R; Shah, CH; Sierakowiak, A; Spira, J; Tu, J; Ullén, A; Viktorsson, K; Zielinska-Chomej, K	1

Other Studies

1 other study(ies) available for phenylalanine and Cancer of the Urinary Tract

Article	Year
Melphalan-flufenamide is cytotoxic and potentiates treatment with chemotherapy and the Src inhibitor dasatinib in urothelial carcinoma. Molecular oncology, 2016, Volume: 10, Issue:5 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Cell Line, Tumor; Dasatinib; Humans; Melphalan; Phenylalanine; Protein Kinase Inhibitors; src-Family Kinases; Urologic Neoplasms; Urothelium	2016

Article

Year

Melphalan-flufenamide is cytotoxic and potentiates treatment with chemotherapy and the Src inhibitor dasatinib in urothelial carcinoma.

Molecular oncology, 2016, Volume: 10, Issue:5

Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Cell Line, Tumor; Dasatinib; Humans; Melphalan; Phenylalanine; Protein Kinase Inhibitors; src-Family Kinases; Urologic Neoplasms; Urothelium

2016